European Nanocharacterization laboratory (EUNCL) meets in Münster

Three years ago, EUNCL was funded as starting community by the European H2020 program with the goal to increase the safety of new nano-based medical products. The representatives and experts from all over Europe met in Münster on May 24th to discuss about the progress in establishing the reference laboratory they set up for the last 3 years and its further development beyond 2019. The partners located in Münster are the only German party involved in EUNCL.

05.06.2018

Nanotechnology offers for example the possibility to deliver anti-cancer agents more targeted and in consequence with less side effects into the tumour. Usually, new drugs are tested regarding their safety for the patient, the same applies for new drugs containing nanotechnology. Hence, the EUNCL partners aim to adapt the established test methods for typical pharmaceutical products to products containing nanoparticles. Thereupon, the newly developed test methods are made available to research groups and SMEs all over Europe. Münster, under the lead of the Gesellschaft für Bioanalytik e.V., is the only party which included not only the University of Münster but also 3 highly qualified SMEs into the consortium of EUNCL. "Aiming to be the reference for nanobioanalytics in Europe, EUNCL has high strategic importance. ", explains Dr. Klaus-Michael Weltring, the Managing Director of the Gesellschaft für Bioanalytik e.V. "Our goal is to be and to stay a central partner for this European reference project in order to establish Münster as the German center for characterization of medical nanomaterials." The counseling meeting showed that Münster is well under way.

Events where you meet EUNCL

More Events ...

European Nanomedicine Characterisation Laboratory (EUNCL)

Call for Proposals!

News

  • EUNCL ExBo Meeting in Liverpool
    The EUNCL ExBo met on 22nd and 23rd November 2018 at University of Liverpool to discuss the actual status of the work in the project and especially in the TNA. The CET and TNA management updated the ExBo on the on-going and the further work planned. The discussion on all questions raised during the meeting was very extensive and important decisions were taken for the last year of the project duration.
  • CLINAM 2018 with EUNCL Participation
    It was the 11th Summit of its kind. CLINAM again welcomed the participants from the community of nanomedicine, targeted drug delivery and precision medicine and bring together the pioneers and worldwide opinion leaders, not only to learn and discuss but also to develop new ideas, create new collaborative projects and shape the future of medicine.
  • Trainee position at JRC (5 months)
    The Consumer Products Safety Unit (F.2), part of Health, Consumers and Reference Materials Directorate-F at the JRC in Ispra (Italy), is looking for a trainee for the Nanobiotechnology laboratory.

More News ...